Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Midazolam for Respiratory Mechanics in ARDS Patients on Mechanical Ventilation
ChiCTR2500114421Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) comparing Midazolam group with Remimazolam group (2 arms). Primary endpoints: Ventilator-free days at day 7 and Ventilator-free days at day 28. Started Dec 2025; status: recruiting.
02
Drugs
remimazolammidazolam
03
Conditions
acute respiratory distress syndrome (ARDS)acute lung injury (ALI)
Beyond the preview
Go deeper on ChiCTR2500114421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114421.